These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29754506)

  • 1. Hirsutella sinensis Inhibits Lewis Lung Cancer via Tumor Microenvironment Effector T Cells in Mice.
    Fu H; Jin L; Shao X; Li Y; Chen F; Shou Z; Tang X; Ji B; Shou Q
    Am J Chin Med; 2018; 46(4):911-922. PubMed ID: 29754506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer.
    Tao Z; McCall NS; Wiedemann N; Vuagniaux G; Yuan Z; Lu B
    Clin Cancer Res; 2019 Feb; 25(3):1113-1124. PubMed ID: 30352911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells.
    Wu T; Liu W; Guo W; Zhu X
    Biomed Pharmacother; 2016 Jul; 81():460-467. PubMed ID: 27261626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways.
    Sawant A; Schafer CC; Jin TH; Zmijewski J; Tse HM; Roth J; Sun Z; Siegal GP; Thannickal VJ; Grant SC; Ponnazhagan S; Deshane JS
    Cancer Res; 2013 Nov; 73(22):6609-20. PubMed ID: 24085788
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Jin L; Jin L; Wu R; Liu X; Zhu X; Shou Q; Fu H
    Front Pharmacol; 2020; 11():612620. PubMed ID: 33488388
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmodium infection inhibits the expansion and activation of MDSCs and Tregs in the tumor microenvironment in a murine Lewis lung cancer model.
    Adah D; Yang Y; Liu Q; Gadidasu K; Tao Z; Yu S; Dai L; Li X; Zhao S; Qin L; Qin L; Chen X
    Cell Commun Signal; 2019 Apr; 17(1):32. PubMed ID: 30979375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
    Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
    Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity.
    Chen ML; Yan BS; Lu WC; Chen MH; Yu SL; Yang PC; Cheng AL
    Int J Cancer; 2014 Jan; 134(2):319-31. PubMed ID: 23818246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 blockade enhances radio-immunotherapy efficacy in murine tumor models.
    Zhuang Y; Li S; Wang H; Pi J; Xing Y; Li G
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1909-1920. PubMed ID: 30074066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of 5-Lipoxygenase in the Tumor Microenvironment Promotes Lung Cancer Progression and Metastasis through Regulating T Cell Recruitment.
    Poczobutt JM; Nguyen TT; Hanson D; Li H; Sippel TR; Weiser-Evans MC; Gijon M; Murphy RC; Nemenoff RA
    J Immunol; 2016 Jan; 196(2):891-901. PubMed ID: 26663781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC9 deficiency promotes tumor progression by decreasing the CD8
    Ning Y; Ding J; Sun X; Xie Y; Su M; Ma C; Pan J; Chen J; Jiang H; Qi C
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
    Li A; Barsoumian HB; Schoenhals JE; Caetano MS; Wang X; Menon H; Valdecanas DR; Niknam S; Younes AI; Cortez MA; Welsh JW
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):903-912. PubMed ID: 30905636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination radiotherapy and cantharidin inhibits lung cancer growth through altering tumor infiltrating lymphocytes.
    Zhang Y; Yang SL; Zhang HR; Gao L; Gao X; Liu PJ; Yi ZY; Li N; Xu ZQ
    Future Oncol; 2017 Jun; 13(13):1173-1180. PubMed ID: 28498036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feiji Recipe inhibits the growth of lung cancer by modulating T-cell immunity through indoleamine-2,3-dioxygenase pathway in an orthotopic implantation model.
    Luo B; Que ZJ; Zhou ZY; Wang Q; Dong CS; Jiang Y; Hu B; Shi H; Jin Y; Liu JW; Li HG; Wang L; Tian JH
    J Integr Med; 2018 Jul; 16(4):283-289. PubMed ID: 29752140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnosic acid enhances the anti-lung cancer effect of cisplatin by inhibiting myeloid-derived suppressor cells.
    Liu W; Wu TC; Hong DM; Hu Y; Fan T; Guo WJ; Xu Q
    Chin J Nat Med; 2018 Dec; 16(12):907-915. PubMed ID: 30595215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced dendritic cell-based immunotherapy using low-dose cyclophosphamide and CD25-targeted antibody for transplanted Lewis lung carcinoma cells.
    Son CH; Bae JH; Lee HR; Shin DY; Yang K; Park YS
    J Immunother; 2015 Apr; 38(3):107-15. PubMed ID: 25751500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells.
    Huang S; Wang Z; Zhou J; Huang J; Zhou L; Luo J; Wan YY; Long H; Zhu B
    Cancer Res; 2019 Apr; 79(8):2009-2020. PubMed ID: 30737232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment.
    Zaynagetdinov R; Sherrill TP; Gleaves LA; McLoed AG; Saxon JA; Habermann AC; Connelly L; Dulek D; Peebles RS; Fingleton B; Yull FE; Stathopoulos GT; Blackwell TS
    Cancer Res; 2015 Apr; 75(8):1624-1634. PubMed ID: 25691457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
    Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
    J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.